BEDFORD, Mass., Sept. 19, 2019 /PRNewswire/ -- Instrumentation Laboratory (IL) today announced commercialization of the HemosIL AcuStar ADAMTS13 Activity Assay in the European Union and other ...
HemosIL AcuStar HIT assays are the first on-demand, fully automated, chemiluminescent reagents on a hemostasis testing system for the detection of antibodies associated with Heparin-Induced ...
Instrumentation Laboratory (IL), Bedford, MA, announced the release of their new HemosIL AcuStar HIT Panel assay that is also now a European CE IVD Marked product.The ACL AcuStar is a fully automated ...
BEDFORD, Mass., April 4, 2017 /PRNewswire/ -- Instrumentation Laboratory (IL) today announced record total worldwide sales in 2016 of $792 M (€716 M). In its two major business segments, Hemostasis ...
BEDFORD, Mass., Sept. 15, 2014 /PRNewswire/ --Instrumentation Laboratory (IL) today announced the commercialization in Europe of their HemosIL Direct Thrombin Inhibitor (DTI) Assay. When used in ...
BEDFORD, Mass., March 3, 2014 /PRNewswire/ -- Instrumentation Laboratory (IL), a company of the Werfen Group, today announced total worldwide sales in 2013 of $741.1M US (EUR558.2M). In its two major ...
"We continued our robust growth trajectory in 2010, despite continued economic pressure in the healthcare industry," said Josep Manent, Chief Executive Officer at IL. "Our products offer customers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results